These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 14286163)

  • 1. SKIN PIGMENTATION, A RARE SIDE EFFECT OF CHLORPROMAZINE.
    BAN TA; LEHMANN HE
    Can Psychiatr Assoc J; 1965 Apr; 10():112-24. PubMed ID: 14286163
    [No Abstract]   [Full Text] [Related]  

  • 2. SLATE-GRAY COLOR IN PATIENTS RECEIVING CHLORPROMAZINE.
    HAYS GB; LYLE CB; WHEELER CE
    Arch Dermatol; 1964 Nov; 90():471-6. PubMed ID: 14200637
    [No Abstract]   [Full Text] [Related]  

  • 3. PIGMENT DEPOSITION IN VISCERA ASSOCIATED WITH PROLONGED CHLORPROMAZINE THERAPY.
    GREINER AC; NICOLSON GA
    Can Med Assoc J; 1964 Sep; 91(12):627-35. PubMed ID: 14201249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEW SIDE EFFECTS IN PROLONGED CHLORPROMAZINE THERAPY.
    GREINER AC; NICOLSON GA
    Can Psychiatr Assoc J; 1965 Apr; 10():109-11. PubMed ID: 14286162
    [No Abstract]   [Full Text] [Related]  

  • 5. THERAPY OF CHLORPROMAZINE MELANOSIS: A PRELIMINARY REPORT.
    GREINER AC; NICOLSON GA; BAKER RA
    Can Med Assoc J; 1964 Sep; 91(12):636-8. PubMed ID: 14201250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [RELATION BETWEEN PHOTOSENSITIVITY AND PATHOLOGIC PIGMENTATION OF THE SKIN WITH HIGH DOSES OF CHLORPROMAZINE].
    BAN TA; LEHMANN HE; GALLAI Z; WARNES H; LEE H
    Union Med Can; 1965 Mar; 94():305-7. PubMed ID: 14331395
    [No Abstract]   [Full Text] [Related]  

  • 7. SKIN PIGMENTATION, CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE TREATMENT.
    MASSEY LW
    Can Med Assoc J; 1965 Jan; 92(4):186-7. PubMed ID: 14232196
    [No Abstract]   [Full Text] [Related]  

  • 8. A NEW AND UNUSUAL REACTION TO CHLORPROMAZINE.
    ZELICKSON AS; ZELLER HC
    JAMA; 1964 Apr; 188():394-6. PubMed ID: 14114032
    [No Abstract]   [Full Text] [Related]  

  • 9. SKIN PIGMENTATION AND CORNEAL AND LENS OPACITIES WITH PROLONGED CHLORPROMAZINE THERAPY.
    GREINER AC; BERRY K
    Can Med Assoc J; 1964 Mar; 90(11):663-5. PubMed ID: 14127375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AN APPARENTLY IRREVERSIBLE SYNDROME OF ABNORMAL MOVEMENTS FOLLOWING PHENOTHIAZINE MEDICATION.
    HUNTER R; EARL CJ; THRONICROFT S
    Proc R Soc Med; 1964 Aug; 57(8):758-62. PubMed ID: 14195882
    [No Abstract]   [Full Text] [Related]  

  • 11. TRANQUILIZERS AND SUICIDE IN THE SCHIZOPHRENIC PATIENT.
    COHEN S; LEONARD CV; FARBEROW NL; SHNEIDMAN ES
    Arch Gen Psychiatry; 1964 Sep; 11():312-21. PubMed ID: 14173124
    [No Abstract]   [Full Text] [Related]  

  • 12. [ATYPICAL ASPECTS OF PIGMENTATION DUE TO SYNTHETIC ANTIMALARIALS (APROPOS OF 2 CASES)].
    PIGUET B; WEISSENBACH R
    Bull Soc Fr Dermatol Syphiligr; 1964; 71():684-91. PubMed ID: 14271122
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of schizophrenic reactions with phenothiazine derivatives. A comparative study of chlorpromazine, triflupromazine, mepazine, prochlorperazine, perphenazine, and phenobarbital.
    CASEY JF; LASKY JJ; KLETT CJ; HOLLISTER LE
    Am J Psychiatry; 1960 Aug; 117():97-105. PubMed ID: 13808146
    [No Abstract]   [Full Text] [Related]  

  • 14. OCULOCUTANEOUS CHANGES AFTER YEARS OF HIGH DOSES OF CHLORPROMAZINE.
    CAIRNS RJ; CAPOORE HS; GREGORY ID
    Lancet; 1965 Jan; 1(7379):239-41. PubMed ID: 14238066
    [No Abstract]   [Full Text] [Related]  

  • 15. THE PURPLE-PEOPLE SYNDROME.
    NAHUM LH
    Conn Med; 1965 May; 29():332. PubMed ID: 14330669
    [No Abstract]   [Full Text] [Related]  

  • 16. PREDRUG BEHAVIOR AS A PREDICTOR OF RESPONSE TO PHENOTHIAZINES AMONG SCHIZOPHRENICS.
    MARKS J
    J Nerv Ment Dis; 1963 Dec; 137():597-601. PubMed ID: 14087681
    [No Abstract]   [Full Text] [Related]  

  • 17. 7-HYDROXYCHLORPROMAZINE: POTENTIAL TOXIC DRUG METABOLITE IN PSYCHIATRIC PATIENTS.
    PERRY TL; CULLING CF; BERRY K; HANSEN S
    Science; 1964 Oct; 146(3640):81-3. PubMed ID: 14173037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THE INCIDENCE AND MANAGEMENT OF CHLORPROMAZINE--SKIN-EYE SYNDROME.
    TREDICI LM; SCHIELE BC; MCCLANAHAN WS
    Minn Med; 1965 May; 48():569-74. PubMed ID: 14274411
    [No Abstract]   [Full Text] [Related]  

  • 19. DERMATOLOGICAL AND OPHTHALMOLOGICAL CHANGES ASSOCIATED WITH PROLONGED CHLORPROMAZINE THERAPY.
    FELDMAN PE; FRIERSON BD
    Am J Psychiatry; 1964 Aug; 121():187-8. PubMed ID: 14194222
    [No Abstract]   [Full Text] [Related]  

  • 20. LONG-TERM THERAPY WITH NEUROTROPIC DRUGS IN PSYCHIATRIC OUTPATIENTS.
    MCLAUGHLIN BE
    GP; 1964 Jul; 30():99-105. PubMed ID: 14155219
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.